Salbutamol dry-powder inhalation - Alkermes
Alternative Names: AlbuLast; Albuterol dry-powder inhalation - AlkermesLatest Information Update: 23 Dec 2021
At a glance
- Originator Alkermes
- Developer Advanced Inhalation Research; Alkermes
- Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Phenethylamines; Phenols; Small molecules; Tocolytics
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 01 Jun 2006 No development reported - Phase-II for Asthma in USA (Inhalation)
- 10 Feb 2003 This programme is still in active development
- 26 Jul 2000 Phase-II clinical trials for Asthma in USA (Inhalation)